ECNP Mini-Conference

The ECNP Mini-Conference at the FENS Forum 2022 showcases the most exciting research in applied and translational neuroscience.

During this event entitled 'What is the mode of action of serotonin psychedelics in brain disorders?', six experts in the field will cover a spectrum of topics from basic neuroscience to novel neuroimaging techniques in studies of humans under influence of psychedelics. 

Saturday 9 July 2022 at 9.00-15.00 (CEST — Central European Summer Time).

Paris Expo Porte de Versailles, Paris, France.
See map here.

Register for free via the button below.

ECNP register here


  • Emma S J Robinson, UK – Investigating the neuropsychological effects of psychedelics and other rapid-acting antidepressants using a translational rodent model
  • Aslihan Selimbeyoglu, UK – Generating translational endpoints for psychedelic therapy development
  • Tomáš Páleníček, Czech Republic – Do animal studies with psychedelics have translational validity? Inputs from behavioural and pharmacoEEG experiments
  • Dino Lüthi, Switzerland – Pharmacology and toxicology of novel psychedelic phenethylamines, tryptamines, and lysergamides
  • Deborah Rudin, Switzerland – Preclinical pharmacological profiling as predictor for the clinical potency and effects of psychedelics
  • Patrick Fisher, Denmark – Neuroimaging effects of psychedelics in humans and perspectives for treatment of patients with major depression

More info about the programme can be found here.

Further information
Participants are entitled to a first day Forum registration to attend all the sessions on 9 July 2022, including the Brain Debate.

The European College of Neuropsychopharmacology (ECNP) is committed to ensuring that advances in the understanding of brain function and behaviour are translated into better treatments for brain disorders and enhanced public health. To achieve these goals, ECNP supports innovative research in neuroscience applied disciplines and facilitate the communication of ideas, discoveries and best practices. In addition, ECNP promotes the entry of Early Career Scientists into the field and support their ongoing professional development, provides guidance and information to the public, and facilitate dialogue with regulators, government bodies, international agencies and industry.

Follow these links to find out more about ECNP and the ECNP Congress, Europe’s largest meeting in applied and translational neuroscience.